Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of NantKwest, Inc. Investors and Encourages Investors to Contact the Firm

IBRX

Glancy Prongay & Murray LLP (“GPM”) announces that a class action lawsuit has been filed on behalf of investors who purchased NantKwest, Inc. (“NantKwest” or the “Company”) (NASDAQ: NK) securities between September 10, 2015 and March 10, 2016, inclusive (the “Class Period”). NantKwest investors have until May 23, 2016 to file a lead plaintiff motion.

Investors who have suffered losses on their NantKwest investments are encouraged to contact Lesley Portnoy of GPM to discuss their legal rights in this class action at 310-201-9150 or by email to shareholders@glancylaw.com.

NantKwest is a biotechnology company that develops immunotherapeutic agents for various clinical conditions.

The Complaint alleges that throughout the Class Period, NantKwest made materially false and misleading statements regarding the Company's business, operational and compliance policies. Specifically, NantKwest made false and/or misleading statements and/or failed to disclose that: (i) NantKwest's financial statements contained errors related to stock-based awards to the Company's Chief Executive Officer and Executive Chairman defendant Patrick Soon-Shiong ("Soon-Shiong"); (ii) NantKwest's financial statements contained errors related to build-to-suit lease accounting related to one of the Company's research and development and good manufacturing practices ("GMP") facilities; (iii) the Company lacked effective internal financial controls; and (iv) as a result of the foregoing, NantKwest's public statements were materially false and misleading at all relevant times.

GPM represents institutional and retail investors in securities class actions throughout the country, and has recovered millions of dollars on behalf of investors.

If you purchased shares of NantKwest during the Class Period you may move the Court no later than May 23, 2016 to ask the Court to appoint you as lead plaintiff if you meet certain legal requirements. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at http://glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Glancy Prongay and Murray LLP, Los Angeles
Lesley Portnoy, 310-201-9150 or 888-773-9224
https://www.glancylaw.com
shareholders@glancylaw.com



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today